2024/10/18 22:00:02 | |
---|---|
Price | |
36.86 USD | |
Difference | 0.57% (0.21) |
ISIN | US0718131099 |
Symbol | BAX |
Exchange | NYSE |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 17,366 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 36.10 USD (100) |
Ask (Ask size) | 37.23 USD (100) |
Open | 36.90 USD |
High | 36.99 USD |
Low | 36.595 USD |
Close (prev. day) | 36.65 USD |
VWAP | 36.814587 USD |
Volume (pcs) | 1,984,343 |
Trading volume | 73,038,403.88 |
Number of trades | 20,899 |
Last size | - |
Related Futures | 14 |
Related Options | - |
Date | Headline | Download | |
2024/09/27 | Global Equity Ratings | ||
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings |
2024/10/18 22:00:02 | |
---|---|
Price | |
36.86 USD | |
Difference | 0.57% (0.21) |
ISIN | US0718131099 |
Symbol | BAX |
Exchange | NYSE |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 17,366 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 36.10 USD (100) |
Ask (Ask size) | 37.23 USD (100) |
Open | 36.90 USD |
High | 36.99 USD |
Low | 36.595 USD |
Close (prev. day) | 36.65 USD |
VWAP | 36.814587 USD |
Volume (pcs) | 1,984,343 |
Trading volume | 73,038,403.88 |
Number of trades | 20,899 |
Last size | - |
6m | 1Y | 3Y | |
Perf (%) | -9.89% | +10.23% | -50.16% |
Perf (abs.) | -3.69 | +3.12 | -33.78 |
Beta | 0.36 | 0.51 | 0.57 |
Volatility | 29.48 | 25.75 | 29.30 |
Ø price 5 days | Ø volume 5 days (pcs.) | 36.77 USD (2,931,683) |
Ø price 30 days | Ø volume 30 days (pcs.) | 37.93 USD (3,613,890) |
Ø price 100 days | Ø volume 100 days (pcs.) | 36.03 USD (4,393,905) |
Ø price 250 days | Ø volume 250 days (pcs.) | 37.51 USD (4,153,907) |
YTD High | date | 44.01 USD (2024/03/08) |
YTD Low | date | 32.48 USD (2024/06/11) |
52 Weeks High | date | 44.01 USD (2024/03/08) |
52 Weeks Low | date | 31.70 USD (2023/10/19) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Vienna Stock Exchange | 2024/10/18 | 17:32 | 33.745 EUR | 0.00 | 5 |
Tradegate | 2024/10/18 | 22:26 | 33.925 EUR | 0.00 | 1 |
Stuttgart | 2024/10/18 | 21:31 | 33.68 EUR | 0.00 | 8 |
NYSE | 2024/10/18 | 22:00 | 36.86 USD | 73.04 | 20,899 |
Munich | 2024/10/18 | 17:26 | 33.665 EUR | 0.00 | 3 |
London Stock Exchange | 2024/09/05 | 11:48 | 37.53 USD | 1.59 | 1 |
Hanover | 2024/10/18 | 17:25 | 33.445 EUR | 0.00 | 4 |
Hamburg | 2024/10/18 | 17:25 | 33.445 EUR | 0.00 | 4 |
Frankfurt | 2024/10/18 | 15:29 | 33.46 EUR | 0.00 | 5 |
Euronext Milan MTF Trading After Hours | 2024/10/09 | 19:00 | 34.43 EUR | 0.01 | 1 |
Euronext Milan MTF Global Equity Market | 2024/10/18 | 17:44 | 33.76 EUR | 0.00 | 1 |
Duesseldorf | 2024/10/18 | 19:30 | 33.775 EUR | 0.00 | 7 |
Berlin | 2024/10/18 | 21:52 | 33.885 EUR | 0.00 | 19 |
BAXTER INTERNATIONAL INC. |
- - |
One Baxter Parkway - 60015-4625 Deerfield |
Telefon: +1-224-948-2000 |
Fax: + |
E-mail: media@baxter.com |
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |
D. Shafer | Member of Board of Directors |
David Wilkes | Member of Board of Directors |
Stephen Oesterle | Member of Board of Directors |
Amy McBride-Wendell | Member of Board of Directors |
Catherine Smith | Member of Board of Directors |
Cathy Smith | Member of Board of Directors |
Jeffrey Craig | Member of Board of Directors |
Nancy Schlichting | Member of Board of Directors |
Patricia Morrison | Member of Board of Directors |
Peter Wilver | Member of Board of Directors |
Stephen Rusckowski | Member of Board of Directors |
William Ampofo | Member of Board of Directors |
José (Joe) E. Almeida | Chairman of Managing Board |
Gerard Greco | Member of Executive Committee |
James W. Borzi | Member of Executive Committee |
Jeanne Mason | Member of Executive Committee |
Joel Grade | Member of Executive Committee |
Talvis Love | Member of Executive Committee |
Tobi Karchmer | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer